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INTRODUCTION
In Indonesia, malaria ranks on the eight place in
the ten deadliest diseases, with 0.7% mortality rate
in the urban area and 1% in the suburban area
(SKRT 2001). In North Sulawesi, based on the data
from the outpatient clinic at public health care, ma-
laria is still in the ten most common diseases. In
1989, malaria was recorded to be the second most
common disease (17%) after common cold and
holds 9% of inpatient rate at various hospitals in
North Sulawesi. Malaria infection in North Sulawesi
were caused by plasmodium falciparum, vivax and
the mixed of both plasmodium.1-3
Pregnant women are very susceptible to malaria
infection because of various causes. A pregnant
women underwent a decline on T cell and LMI
(Leukocyte Migration Inhibition Index) percentage
and if a pregnant women are infected with malaria,
the decrease will be more radical.2,4
Abstract
Objective: To detect malaria by PCR examination of saliva in preg-
nant women and to obtain the incidence of malaria and the type of
plasmodium causing malaria in pregnant women at various hospital
in North Sulawesi.
Method: A descriptive cross sectional study in pregnant women
during antenatal care at the Department of Obstetrics and Gynecol-
ogy Faculty of Medicine University of Sam Ratulangi/Prof. Dr. R.D.
Kandou General Hospital in Manado, R.W. Monginsidi Hospital in
Manado, Bethesda Hospital in Tomohon, and Datoe Binangkang
Hospital in Kotamobagu, from 1 April until 31 May 2008.
Result: There were 43 pregnant women clinically diagnosed with
malaria, 23 (53.49%) by PCR examination of saliva and 20 (46.59%)
by blood smears. From 23 cases of malaria in pregnancy detected by
PCR, there were 18 diagnosed as tropical malaria, 3 tertian malaria,
and 2 mixed malaria.
Conclusions: The incidence of malaria in pregnancy at various hos-
pital in North Sulawesi using PCR methods for saliva examination
from April 1 - May 31 2008 is 53.49%. In this study malaria are
mostly caused by Plasmodium falciparum with the largest incidence
in primigravida, in the first trimester.
[Indones J Obstet Gynecol 2012; 36-1:14-9]
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Abstrak
Tujuan: Untuk mendeteksi malaria dengan PCR melalui saliva perem-
puan hamil dan mengetahui angka kejadian malaria pada perempuan
hamil serta jenis plasmodium penyebab malaria pada perempuan
hamil di beberapa rumah sakit di Sulawesi Utara.
Metode: UJi potong lintang pada perempuan hamil yang melakukan
pemeriksaan antenatal di Bagian/SMF Obstetri dan Ginekologi Fakul-
tas Kedokteran Unsrat/RSUP Prof. Dr. R.D. Kandou di Manado, RS R.W.
Monginsidi di Manado, RS Bethesda di Tomohon dan RS Datoe Bi-
nangkang di Kotamobagu sejak 1 April - 31 Mei 2008.
Hasil: Sejak 1 April - 31 Mei 2008 didapatkan 43 perempuan hamil
yang diduga malaria secara klinis, 23 (53,49%) dinyatakan positif ma-
laria dengan pemeriksaan PCR terhadap spesimen saliva dan 20
(46,59%) dengan apusan darah. Dari 23 perempuan yg terdeteksi po-
sitif malaria melalui PCR, 18 pasien didiagnosis sebagai malaria tropi-
kana, 3 pasien malaria tertiana, dan 2 pasien mixed malaria.
Kesimpulan: Kejadian malaria pada perempuan hamil tersangka
klinis malaria pada beberapa RS di Sulawesi Utara menggunakan me-
tode PCR melalui spesimen saliva periode 1 April - 31 Mei 2008 adalah
sebesar 53,49%. Jenis plasmodium terbanyak pada penelitian ini
adalah Plasmodium falciparum dan angka kejadian malaria tertinggi
ditemukan pada primigravida, pada trimester pertama.
[Maj Obstet Ginekol Indones 2012; l 36-1:14-9]
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Clinical manifestation of malaria in pregnant
women depended on the immunity level of the
women. The immunity depended on the transmis-
sion rate at the place where the women live. In an
endemic malaria area like North Sulawesi, where
women are always exposed to infected mosquitoes
every months, the malaria immunity developed
significantly. The most susceptible group to be in-
fected with malaria in these areas is pregnant
women.3,4
Laboratory diagnosis on malaria is established
by various methods such as microscopic examina-
tion, QBC examination, immunoserological exami-
nation and biomolecular examination. In a situ-
ation where the level of parasites in the blood are
low (low parasitemia) and the symptoms are un-
common or even asymptomatic, microscopic find-
ings are less sensitive compared to QBC methods
and other dipstick examinations. PCR has a higher
sensitivity compared to other examinations.5-8
PCR examinations in malaria can be used in
cases when a patient highly suspected for malaria
but the microscopic examinations are negative, to
confirm and identified the type of plasmodium and
to monitor the responds to medication especially
in potentially resistance area.5-8
With new information of the parasite life cycle,
detection and screening for malaria infection
through blood sampling (finger tip or vein) are
needed. But this brings difficulties in some commu-
nities, where they have beliefs that blood sampling
are taboo and can cause some limitations. Needle
utilization needs skills and more budgets, but in
this study we used saliva to detect P. falciparum
with PCR. Thus, detection of malaria infection un-
derwent improvement in sampling method. Screen-
ing of parasites in large scales and for epidemiol-
ogy surveys can be accomplished without blood
sampling and needle utilization.5-8
METHOD
This is a descriptive cross sectional study in preg-
nant women during antenatal care at the Depart-
ment of Obstetrics and Gynecology Faculty of Medi-
cine University of Sam Ratulangi/Prof. Dr. R.D. Kan-
dou General Hospital in Manado, R.W. Monginsidi
Hospital in Manado, Bethesda Hospital in Tomo-
hon, and Datoe Binangkang Hospital in Kotamo-
bagu from 1 April until 31 May 2008.
SAMPLING CRITERIA
Inclusion Criteria
Every women that was confirmed as pregnant, sus-
pected clinically of having malaria, and agreed to
participate in this study.
Exclusion Criteria
Pregnant women diagnosed with malaria, or al-
ready on malaria therapy.
OPERATIONAL FRAMEWORK
The pregnancy is confirmed if definite pregnancy
signs are positive.
Pregnant women was diagnosed with malaria by
doctor based on the previous laboratory examina-
tion.
Pregnant women on malaria therapy is a preg-
nant women diagnosed with malaria and is on anti
malaria medication.
The diagnosis of malaria is clinically suspected
if there were signs and symptoms such as fever,
shivering, headache, decreased appetite, nausea
and vomiting.
Malaria PCR is a genotype and biomolecular ex-
amination to detect plasmodium DNA, in this case
specific parasite nucleotides.
Positive Nested-PCR means that the DNA of ma-
laria parasite was found using PCR technique.
Negative Nested-PCR means that the DNA of ma-
laria parasite was not found using PCR technique.
INSTRUMENTS
Basic data quesioner, Instruments and PCR re-
agents, Primer nested PCR, Instruments and elec-
troforesis reagents.
PROCEDURE
Research approval
The study is carried out after the patients met the
study criteria, receive good explanation of the
study and signed a research consent. Basic data
quesioner was filled by research officer. Data was
recorded and included in the research status and
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registration. One to five ml of saliva was taken by
sputtering in a dish given and was stored under
-20° C temperature.
DNA extraction
300 μl saliva was added with 900 μl buffer lysis
cell, mixed throughly for 10 minutes in 4° C tem-
perature, then centrifuged for 10 minutes. The su-
pernatant in the centrifuge was disposed and 300
μl nucler invers solution on pelet was added and
mixed by vortex and incubated for 2 hours or
through the night in 55° C temperature or then 200
μl protein precipitation solution was added. It is
stirred for 20 seconds, then centrifuged for 10 min-
utes with maximum speed. Tube filled with 1 μl
reagent was prepared, the supernatant was taken
and placed in a new container, 2 propanolol was
added, mixed throughly for 15 minutes in maxi-
mum speed. The supernatant was disposed after-
wards, then it was rinsed with 70% ethyl alcohol,
dried for 3.5 minutes, and 50 μl dehidration solu-
tion was added. Then DNA and TrisEDTA was
mixed. Sampel was stored in – 20° C before used.
PCR reaction
Primer that was used in this nested PCR study can
amplificate a DNA segment and gene found in plas-
modium. The first primary pair will produce a DNA
segment of 262 pair. The second base primer is
specific for Plasmodium sp.
PCR amplification
PCR mixture was prepared with volume reaction
as many as 25 μl for every PCR tube: 17 μl sterile
aquabidest, 10XPCR buffer + MgCl2 2.5 μl, 10 mMol
dNTPs 2 μl, 0.25 μl enzyme, each 0.5 μl primer and
3 μl DNA template. The first PCR stage used Primer
P1F-Up and P1R, and for the second stage used P1F
and each specific primer. The first stage PCR prod-
uct was then diluted to a final concentration of 50
times and was used as templates for the second
PCR stage.
The PCR machine (Perkin Elmer) was pro-
grammed for 30 amplification cycle in phase I and
35 cycles in phase II. The parameters used for the
PCR cycle Phase I includes the initial denaturation
for 7 minutes at a temperature of 95° C, denatura-
tion for 30 seconds at a temperature of 95° C, an-
nealing for 30 seconds at a temperature of 55° C,
polymerization for 30 seconds at a temperature of
72° C and extension for 7 min at 72° C.
The parameters used for the PCR cycle phase II
includes the early denaturation for 7 minutes at a
temperature of 95° C, denaturation for 30 seconds
at a temperature of 95° C, annealing for 30 seconds
at a temperature of 55° C, polymerization for 30
seconds at a temperature of 72° C polymerization
and extension for 7 min at 72° C, then the tempera-
ture lowered to 4° C.
Reading of the PCR
Agar material was prepared by dissolving 1.5 g
agarose in 100 ml of lx TBE buffer, and then added
to 5 μl ethidium bromide that is mutagenic, heated
until boiling. It was then printed using a comb as
a shaper of the wells. A total of 8 μl sample of PCR
was then mixed with 2 μl loading dye and then
poured into 1.5% agar wells. As the marker 10 μl
100 bp DNA ladder was used. Electrophoresis was
carried out for 20 minutes at a voltage 100 volts.
Visualization of the results of electrophoresis can
be performed by trans-illuminator using ultraviolet
light and photographed with a Polaroid camera as
documentation.
RESEARCH ETHICS
All pregnant women who participated in this study
had undergone counseling and had received expla-
nation of the purpose and objectives of this study.
If the woman agreed, then she must sign a letter
of informed consent. When a woman was found
positive for malaria in this study, then a proper
step of treatment was carried out.
DATA ANALYSIS
In this study, data was collected, assessed, tabu-
lated and presented in tables and percentages.
RESULTS
This research was conducted from April 1st to May
31, 2008. During the study, there were 43 pregnant
women clinically suspected with malaria who un-
derwent in-patient and ambulatory care in Map re-
search hospitals, namely: 6 patients at the Prof. Dr.
R.D. Kandou General Hospital in Manado, 24 pa-
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tients at the Wolter Monginsidi Hospital, 7 patients
at Datoe Binangkang General Hospital in Kotamo-
bagu, 6 patients at Bethesda Hospital in Tomohon.
Of the 43 pregnant women clinically suspected
malaria, there were 23 positive pregnant women
with malaria confirmed with PCR through saliva
specimens. Among them, there were 18 women di-
agnosed with tropical malaria (Plasmodium falci-
parum), 3 pregnant women with tertian malaria
(Plasmodium vivax), and 2 pregnant women with
mixed malaria (Plasmodium falciparum and Plas-
modium vivax).
In this study, there were 23 (53.49%) pregnant
women diagnosed with malaria infection by PCR
and 20 (46.59%) by blood smear. The results were
quite high; this could be due to the time of sam-
pling which occurred in April to May which is the
rainy season. Based on the literature it was said
that the rainy season associated with 5 fold the risk
of clinical malaria and 2 fold the risk of parasitemia
compared to the dry season.6,9
These results are similar to those found in
Ghana where Mockenhaupt et al found that of 839
pregnant women examined with suspected ma-
laria, PCR methods diagnosed malaria infections by
52.9%, while blood smear only diagnosed 19% of
malaria infection. Tjitra research in eastern Indo-
nesia also found that 50% of clinically suspected
malaria infected were malaria positive.10,11
Pregnant women are highly vulnerable to ma-
laria infection because of several things. There
were a decreased percentage of T cells and LMI
(Leucocytes Migration Inhibition Index) and if the
woman is infected with malaria, they will further
decrease.2,4,9
Table 1. Characteristics of Samples
  Characteristics n = 43 %
Age
≤ 20
21 - 25
26 - 30
> 30
12
 7
16
 8
27.9
16.3
37.2
18.6
Parity
Prim gravidity
Secondary gravidity
Multi gravidity
19
 9
15
44.2
20.9
34.9
Gestasional Age
< 13 weeks
13 - 28 weeks
> 28 weeks
 8
16
19
18.6
37.2
44.2
In Walker’s study, age and gravidity did not af-
fect the prevalence of malaria infection sub micro-
scopically in pregnant women in Cameroon. Nyunt
et al (2003) conducted a study in southern Zambia
and found that the average age of pregnant women
with malaria was 26 years (21-39 years).12-14
In Table 2, the type of Plasmodium causing ma-
laria were Plasmodium falciparum in 18 patients
(77.3%), Plasmodium vivax in 3 patients (13.6%)
and mixed Plasmodium in 2 patients (9.1%). From
the literature, pregnant women are more suscepti-
ble to the infection of P. falciparum. This happens
because only P. falciparum underwent sequestra-
tion, and other plasmodium cycles entirely oc-
curred in the peripheral blood vessels. Sequestra-
tion occurs in vital organs and virtually all tissues
in the body.4 Pregnant women have the possibility
of infected with malaria falciparum more frequent
and severe compared to non pregnant women. In
endemic areas such as North Sulawesi Province,
the most common cause of malaria was Plasmo-
dium falciparum. In Walker’s research Plasmodium
falciparum infection to be the most common cause
of malaria, found in 76.1% malaria patients. Plas-
modium falciparum and Plasmodium malariae
mixed infection is found in 6.9%, Plasmodium fal-
ciparum and Plasmodium ovale mixed infection in
1.8% and the mixed infection of Plasmodium falci-
parum, Plasmodium malariae and Plasmodium
ovale was 0.7%.16
Table 2. Distribution of malaria based on parity
Malaria
P.
Falciparum
P.
Vivax
Mixed
Malaria
n % n % n %
Prim gravidity
(n=19)
10 47.4 2 10.5 1 5.3
Secondary gravidity
(n=9)
 4 44.4 1 11.1 0 0.0
Multi gravidity
(n=15)
 4 26.7 0  0.0 1 6.7
Out of 43 pregnant women clinically suspected
malaria, 47.4% is primigravida, 44.4% is secondary
gravidity, and 26.7% is multigravida. Some studies
also mention the highest prevalence of malaria in-
fection in pregnancy was the first and second
gravidity with a high parasite density. From the lit-
erature, malaria infection was also determined by
the patient immune factors. Individual immunity
against malaria is influenced by several factors, one
of which is derived factor (active immunity) follow-
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ing a recurrent infection, and it is increasing simul-
taneously with the increasing age and parity. This
means that the younger the age of a woman in her
first pregnancy, the more likely she is to be infected
with malaria. The reduced risk of malaria with in-
creasing parity has been reported in some studies,
especially in women who are semi immune.9,13,15,16
The same study conducted by Coulibaly et al
showed the results of 56.7% in primigravida,
43.6% in secondary gravidity and 20.2% in multi-
gravida.17
The result showed that the incidence of malaria
caused by Plasmodium falciparum infection in
women of gestational age <13 weeks and 13 - 28
weeks are 50% and in women with gestational age
over 28 weeks is 26.3%. P. vivax infection in
women of gestational age of 13 - 28 weeks is 13%,
and over 28 weeks is 5%. Mixed malaria at the
gestational age of <13 weeks is 12.5% and over 28
weeks is 5.3%. Zhou et al also stated that the first
trimester had the highest risk of malaria infection.
Immunity against malaria began to decrease in
pregnant women in the third trimester of preg-
nancy. According to Zhou, malaria infection in
pregnant women are more prone to occur in the
first trimester because at that period there was a
decline in proliferative response of T cells result-
ing in decreased immunity seluler.16
Nyunt et al (2003) in their study found 40% of
women suffered from malaria is in their late se-
cond trimester and third trimester of pregnancy.
While Coulibaly found 55.9% pregnant women in-
fected with malaria at their earlier pregnancy with
a peak at 9-16 weeks of gestation.14
CONCLUSION
The incidence of malaria in pregnant women clini-
cally suspected malaria at the Prof. Dr. R.D. Kandou
General Hospital, Wolter Monginsidi Hospital, Da-
toe Binangkang Hospital, and Bethesda Hospital in
Tomohon using PCR methods through saliva speci-
mens from 1 April to 31 May 2008 was 53.49%.
The type of plasmodium causing malaria in this
study was Plasmodium falciparum with the highest
incidence of malaria was found in primi gravida
and in the first trimester. PCR Method were slightly
more accurate in malaria detection compared to
microscopic examination.
SUGGESTION
Further research can be done to make the PCR with
saliva specimens as a standard test on suspected
cases of malaria in endemic areas.
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